VivoGenie Anti-TNF alpha (Adalimumab) Biosimilar (Fc Reduced) (IVMB0206)
(No reviews yet)
Write a Review
- SKU:
- IVMB0206
- Product Type:
- Biosimilar In Vivo Antibody
- Protein:
- TNFa
- Clone:
- D2E7
- Isotype:
- IgG1 kappa
- Reactivity:
- Human
- Synonyms:
- DIF, TNFA, TNFSF2, TNLG1F, TNF-alpha
- Antibody Type:
- In Vivo Biosimilar
- Endotoxin Level:
- Low Endotoxin
- Applications:
- In Vivo
Frequently bought together:
Description
| Product Name: | VivoGenie Anti-TNF alpha (Adalimumab) Biosimilar Antibody - Low Endotoxin (Fc Reduced) |
| Product Code: | IVMB0206 |
| Size: | 500 µg |
| Clone: | D2E7 |
| Protein: | TNF alpha |
| Product Type: | Biosimilar Recombinant Human Monoclonal Antibody |
| Synonyms: | DIF, TNFA, TNFSF2, TNLG1F, TNF-alpha |
| Isotype: | Human IgG1κ |
| Reactivity: | Human |
| Immunogen: | Human TNF alpha |
| Applications: | B, ELISA, FA, FC, IF, IHC, IP, N |
| Formulation: | This biosimilar antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
| Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
| Purity: | >95% by SDS-PAGE and HPLC |
| Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
| Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
| Applications: | B, ELISA, FA, FC, IF, IHC, IP, N |
| Recommended Usage: | FC The suggested concentration for Adalimumab biosimilar antibody for staining cells in flow cytometry is ≤ 0.25 µg per 106 in a volume of 100 µl. Titration of the reagent is recommended for optimal performance for each application. |
| Reactivity: | Human |
| Specificity: | This non-therapeutic biosimilar antibody uses the same variable region sequence as the therapeutic antibody Adalimumab. Clone D2E7 binds to soluble TNF- α, but not to TNF- ? (lymphotoxin). This product is for research use only. |
| Antigen Distribution: | TNF-α is secreted by macrophages, monocytes, neutrophils, T cells, B cells, NK cells, LAK cells. |
| Immunogen: | Human TNF alpha |
| Concentration: | ≥ 5.0 mg/ml |
| Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
| Purity: | >95% by SDS-PAGE and HPLC |
| Formulation: | This biosimilar antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
| Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
| Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles. |
| Protein: | TNF alpha |
